Leadership
Drugmaker seeks approval for China’s first biosimilar Ozempic
A DRUGMAKER in China has developed a biosimilar version of Novo Nordisk’s popular diabetes drug Ozempic and applied for approval to sell it there, in a potential challenge to...
HSBC chairman says Asia business spinoff ‘will not happen’
HSBC chairman Mark Tucker told the bank’s shareholders in Hong Kong on Wednesday (Apr 3) that a spinoff of its Asian business will not happen.“There is no appetite among...
Temasek appoints two new directors to its board
SINGAPORE’S Temasek Holdings has appointed two new directors to its board – Tan Chong Meng, who assumed the role on Apr 1, 2024, and Geoffrey Wong, whose appointment takes...
Passenger car COEs all rise, Category B back above S$100,000
CERTIFICATE of Entitlement (COE) premiums for passenger cars all rose in April’s first round of bidding, with the category for larger, more powerful cars rising above S$100,000 after a...
Car shows drive COE hikes; Category B back above S$100,000
CERTIFICATE of Entitlement (COE) premiums for passenger cars all rose in April’s first round of bidding, with the category for larger, more powerful cars rising above S$100,000 after a...
Passenger car COEs rise, Category B back above S$100,000
CERTIFICATE of Entitlement (COE) premiums for passenger cars all rose in April’s first round of bidding, with the category for larger, more powerful cars rising above S$100,000 after a...
Chinese smartphone maker Xiaomi starts delivering the first of more than 100,000 EVs ordered
CHINESE smartphone maker Xiaomi on Wednesday (Apr 3) said it has received more than 100,000 orders for its first car – a sporty electric vehicle (EV) called the SU7...
Singtel slides amid heavy trading on reports of scuppered Optus deal; calls for trading halt
SINGTEL : Z74 0% requested a trading halt on Wednesday (Apr 3) morning after falling as much as 4.3 per cent in early trading.This came after Australian media reported...
